Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LTRN
LANTERN PHARMA INC.
NASDAQ
$2.07
▼ DOWN 4.17% (-0.09)

KEY STATISTICS

Market Cap$26.41 M
52w High$4.70
52w Low$1.11
Dividend Yield—
Frequency—
P/E-1.28
Volume91.74K
Shares Out.12.76M

COMPANY

LEADERSHIP

Panna Sharma
CHIEF EXECUTIVE
Panna Sharma

COMPENSATION 2026

Salary$575,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$10,350
Total$1,090,634

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 11, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
16

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.—
NOV
11
WED

PRICE

$2.07 ▼ DOWN 4.17% (−$0.09)
$2.08$2.12$2.169:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.07

About Lantern Pharma Inc.

https://www.lanternpharma.com ↗

Lantern Pharma Inc. is a Dallas-based biotech company utilizing AI, machine learning, and genomic data to develop cancer therapies, including LP-100, LP-300, LP-184, and ADC programs, with several in clinical and preclinical stages.

INDUSTRY

Biotechnology

A PRODUCT LANTERN PHARMA INC. IS KNOWN FOR

LP-284
LP-284

LP-284 is a clinical-stage, novel small molecule with a synthetic lethal mechanism targeting DNA repair deficiencies in cancers, recently receiving FDA Orphan Drug Designation for soft tissue sarcomas in January 2026.

COMPETITORS

COMPETITOR
AUTL COMPARE
CTOR COMPARE
MBRX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
14
LISTED HERE
3
RANKED BY POSITION SIZE
VTS.AX
0.00% · 338.4K
MEDX
0.27% · 22.7K
DFSU
0.00% · 1.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
17.23%
HOLDERS
42
TOP 12 OF 42 · RANKED BY POSITION SIZE
Bios Capital Management, LP
1.0M sh · $4.42M
Vanguard Group Inc
384.0K sh · $1.16M
Cm Management, LLC
250.0K sh · $342.5K
Renaissance Technologies LLC
116.0K sh · $158.92K
Geode Capital Management, LLC
111.6K sh · $152.98K
Newedge Advisors, LLC
56.5K sh · $178.56K
Westside Investment Management, Inc.
50.0K sh · $68.57K
Voss Capital, LLC
50.0K sh · $68.5K
Blackrock, Inc.
45.3K sh · $62.02K
Dimensional Fund Advisors LP
40.1K sh · $174.63K
Blackrock Inc.
39.8K sh · $186.06K
Susquehanna International Group, Llp
39.1K sh · $170.06K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
KEYSER D JEFFREY
Purchase · 48.5K shares
2026-05-12
★
DIRECTOR
KEYSER D JEFFREY
Purchase · 48.5K shares
2026-05-12
★
DIRECTOR
Schalop Lee Troy
Purchase · 48.5K shares
2026-05-12
★
DIRECTOR
Schalop Lee Troy
Purchase · 48.5K shares
2026-05-12

SECTORS PEERS

PEERPRICE
RNXT$1.67COMPARE
ANVS$1.72COMPARE
ELUT$0.88COMPARE
TVRD$1.82COMPARE
CALC$0.46COMPARE
RVPH$0.52COMPARE
BCAB$1.74COMPARE